🇺🇸 FDA
Pipeline program

Nadunolimab

STUDY-25-00756

Phase 2 small_molecule active

Quick answer

Nadunolimab for Metastatic Microsatellite Stable Colorectal Carcinoma is a Phase 2 program (small_molecule) at Coherus Oncology with 1 ClinicalTrials.gov record(s).

Program details

Company
Coherus Oncology
Indication
Metastatic Microsatellite Stable Colorectal Carcinoma
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials